Melanoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) |
||
| Line 21: | Line 21: | ||
* Patient education regarding monthly self-skin exams | * Patient education regarding monthly self-skin exams | ||
* Patient education regarding self-lymph node exam | * Patient education regarding self-lymph node exam | ||
*Chest x-ray and measurement of CBC and LDH every 6-12 months may be considered (optional) | |||
===Stage IIB-IV at Diagnosis=== | ===Stage IIB-IV at Diagnosis=== | ||
*Imaging screening | *Imaging screening by annual brain MRI AND either chest X-ray, positron emission tomography (PET), or CT scan (preferred) every 3-12 months for the first 5 years. | ||
* Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter | *Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter | ||
*Measurement of CBC and LDH every 6-12 months may be considered (optional) | |||
* Patient education regarding monthly self-skin exams | * Patient education regarding monthly self-skin exams | ||
* Patient education regarding self-lymph node exam | * Patient education regarding self-lymph node exam | ||
Revision as of 01:07, 22 August 2015
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Melanoma secondary prevention |
|
Risk calculators and risk factors for Melanoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
The choice of work-up for secondary prevention of melanoma is based on the stage of melanoma at diagnosis. Secondary prevention includes routine dermatologic evaluations, monthly self-exams, and chest and brain imaging.
Secondary Prevention
The National Comprehensive Cancer Network (NCCN) recommends the following:[1]
Stage 0 at Diagnosis
- Annual dermatologic evaluation for life
- Patient education regarding monthly self-skin exams
Stage IA at Diagnosis
- Dermatologic evaluation every 3-12 months for the first 5 years following diagnosis then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
Stage IB-IIA at Diagnosis
- Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
- Chest x-ray and measurement of CBC and LDH every 6-12 months may be considered (optional)
Stage IIB-IV at Diagnosis
- Imaging screening by annual brain MRI AND either chest X-ray, positron emission tomography (PET), or CT scan (preferred) every 3-12 months for the first 5 years.
- Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter
- Measurement of CBC and LDH every 6-12 months may be considered (optional)
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
References
- ↑ Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.